Works by Miller, Timothy M.
Results: 60
Access for ALL in ALS: A large‐scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2024, v. 70, n. 6, p. 1140, doi. 10.1002/mus.28244
- By:
- Publication type:
- Article
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.
- Published in:
- Journal of Neuroscience, 2017, v. 37, n. 22, p. 5574, doi. 10.1523/JNEUROSCI.3582-16.2017
- By:
- Publication type:
- Article
Antisense Reduction of Tau in Adult Mice Protects against Seizures.
- Published in:
- Journal of Neuroscience, 2013, v. 33, n. 31, p. 12887, doi. 10.1523/JNEUROSCI.2107-13.2013
- By:
- Publication type:
- Article
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 12, p. 1312, doi. 10.1001/jamaneurol.2022.3282
- By:
- Publication type:
- Article
CNS microRNA profiles: a database for cell type enriched microRNA expression across the mouse central nervous system.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61307-5
- By:
- Publication type:
- Article
Evaluating the efficacy of purchased antisense oligonucleotides to reduce mouse and human tau in vivo.
- Published in:
- Frontiers in Molecular Neuroscience, 2023, p. 1, doi. 10.3389/fnmol.2023.1320182
- By:
- Publication type:
- Article
A Path to High-Efficiency Optical Coupling for HIRMES.
- Published in:
- Journal of Low Temperature Physics, 2018, v. 193, n. 5/6, p. 681, doi. 10.1007/s10909-018-1939-7
- By:
- Publication type:
- Article
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30387-4
- By:
- Publication type:
- Article
O.15: Distinct tau prion strains propagate in cells and mice and define different tauopathies.
- Published in:
- Prion, 2014, v. 8, p. 18
- By:
- Publication type:
- Article
Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.
- Published in:
- Molecular Neurodegeneration, 2017, v. 12, p. 1, doi. 10.1186/s13024-017-0217-5
- By:
- Publication type:
- Article
Oil and Gas Operations on Public Lands in the Marcellus Shale Region.
- Published in:
- Energy & Mineral Law Institute, 2011, n. 32, p. 516
- By:
- Publication type:
- Article
Is It a Deep Well or a Shallow Well and Who Cares?
- Published in:
- Energy & Mineral Law Institute, 2010, n. 31, p. 403
- By:
- Publication type:
- Article
Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational Studies.
- Published in:
- JMIR mHealth & uHealth, 2022, v. 10, n. 2, p. 1, doi. 10.2196/31877
- By:
- Publication type:
- Article
Lumbar punctures are safe in patients with ALS and have a risk profile similar to that in the non‐ALS population.
- Published in:
- Muscle & Nerve, 2023, v. 68, n. 5, p. 771, doi. 10.1002/mus.27956
- By:
- Publication type:
- Article
Incidence of amyotrophic lateral sclerosis in older adults.
- Published in:
- Muscle & Nerve, 2022, v. 66, n. 3, p. 289, doi. 10.1002/mus.27652
- By:
- Publication type:
- Article
Smartphone data during the COVID‐19 pandemic can quantify behavioral changes in people with ALS.
- Published in:
- Muscle & Nerve, 2021, v. 63, n. 2, p. 258, doi. 10.1002/mus.27110
- By:
- Publication type:
- Article
Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CK-2127107 amplifies skeletal muscle response to nerve activation in humans.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reply.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2015, v. 52, n. 3, p. 339, doi. 10.1002/mus.24688
- By:
- Publication type:
- Article
Differential diagnosis of myotonic disorders.
- Published in:
- Muscle & Nerve, 2008, v. 37, n. 3, p. 293, doi. 10.1002/mus.20923
- By:
- Publication type:
- Article
Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes.
- Published in:
- Annals of Neurology, 2015, v. 77, n. 1, p. 100, doi. 10.1002/ana.24306
- By:
- Publication type:
- Article
Progressive spinal axonal degeneration and slowness in ALS2‐deficient mice.
- Published in:
- Annals of Neurology, 2006, v. 60, n. 1, p. 95
- By:
- Publication type:
- Article
Virus‐delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.
- Published in:
- Annals of Neurology, 2005, v. 57, n. 5, p. 773
- By:
- Publication type:
- Article
TREM2 Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 4, p. 449, doi. 10.1001/jamaneurol.2013.6237
- By:
- Publication type:
- Article
Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives.
- Published in:
- Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2024, v. 25, n. 7/8, p. 672, doi. 10.1080/21678421.2024.2396831
- By:
- Publication type:
- Article
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.
- Published in:
- Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2023, v. 24, n. 5/6, p. 523, doi. 10.1080/21678421.2023.2216223
- By:
- Publication type:
- Article
MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
- Published in:
- Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2023, v. 24, n. 3/4, p. 304, doi. 10.1080/21678421.2022.2154678
- By:
- Publication type:
- Article
Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial.
- Published in:
- Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2022, v. 23, n. 3/4, p. 263, doi. 10.1080/21678421.2021.1946083
- By:
- Publication type:
- Article
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.
- Published in:
- Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2021, v. 22, n. 3/4, p. 287, doi. 10.1080/21678421.2020.1822410
- By:
- Publication type:
- Article
Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
MicroRNA signature of central nervous system‐infiltrating dendritic cells in an animal model of multiple sclerosis.
- Published in:
- Immunology, 2018, v. 155, n. 1, p. 112, doi. 10.1111/imm.12934
- By:
- Publication type:
- Article
Plasma neurofilament light predicts mortality in patients with stroke.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 569, p. 1, doi. 10.1126/scitranslmed.aay1913
- By:
- Publication type:
- Article
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 374, p. 1, doi. 10.1126/scitranslmed.aag0481
- By:
- Publication type:
- Article
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS.
- Published in:
- Journal of Medical Economics, 2023, v. 26, n. 1, p. 488, doi. 10.1080/13696998.2023.2192588
- By:
- Publication type:
- Article
Protective Effects of Lovastatin in a Population‐Based ALS Study and Mouse Model.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 5, p. 881, doi. 10.1002/ana.26600
- By:
- Publication type:
- Article
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Specific RNA interactions promote TDP‐43 multivalent phase separation and maintain liquid properties.
- Published in:
- EMBO Reports, 2021, v. 22, n. 12, p. 1, doi. 10.15252/embr.202153632
- By:
- Publication type:
- Article
Targeted ASO-mediated Atp1a2 knockdown in astrocytes reduces SOD1 aggregation and accelerates disease onset in mutant SOD1 mice.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0294731
- By:
- Publication type:
- Article
Has gene therapy for ALS arrived?
- Published in:
- Nature Medicine, 2003, v. 9, n. 10, p. 1256, doi. 10.1038/nm1003-1256
- By:
- Publication type:
- Article
Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 9, p. 1803, doi. 10.1093/hmg/ddw052
- By:
- Publication type:
- Article
Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 20, p. 4127, doi. 10.1093/hmg/ddt261
- By:
- Publication type:
- Article
In vivo kinetic approach reveals slow SOD1 turnover in the CNS.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 7, p. 2772, doi. 10.1172/JCI80705
- By:
- Publication type:
- Article
Antisense oligonucleotide therapy for neurodegenerative disease.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A.
- Published in:
- eLife, 2020, p. 1, doi. 10.7554/eLife.61119
- By:
- Publication type:
- Article
Investigating 4R tau isoform imbalance as a mediator of astrocyte dysfunction in tauopathies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076609
- By:
- Publication type:
- Article
Targeted Atp1a2 knockdown by antisense oligonucleotides leads to reduced SOD1 aggregation and accelerated disease progression in the SOD1*G93A mouse model of ALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.058737
- By:
- Publication type:
- Article
O4‐02‐02: TARGETING THE ALZHEIMER'S DISEASE‐ASSOCIATED RISK GENE, TREM2, WITH ANTISENSE OLIGONUCLEOTIDES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1402, doi. 10.1016/j.jalz.2018.06.2916
- By:
- Publication type:
- Article
O3‐01‐03: TAU KINETICS IN NEURONS AND IN THE HUMAN CNS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1008, doi. 10.1016/j.jalz.2018.06.2772
- By:
- Publication type:
- Article